ArticleTranslational cancer research2019

Akt/mTOR and AMPK signaling pathways are responsible for liver X receptor agonist GW3965-enhanced gefitinib sensitivity in non-small cell lung cancer cell lines.

Qingbo Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.